Regulation of histone acetylation by autophagy in Parkinson disease

Journal of Biological Chemistry

Volumn 291, Issue 7, 2016, Pages 3531-3540

  Park, Goonho ^a,b   Tan, Jieqiong ^c   Garcia, Guillermina ^a   Kang, Yunyi ^a   Salvesen, Guy ^a   Zhang, Zhuohua ^a,c  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Central South University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLATION; ACTIVATION ANALYSIS; CELL DEATH; MAMMALS; NEURODEGENERATIVE DISEASES; NEURONS; PATIENT TREATMENT;

1-METHYL-4-PHENYLPYRIDINIUM; CULTURED HUMAN CELL; DOPAMINERGIC NEURONS; ENVIRONMENTAL FACTORS; EPIGENETIC MECHANISMS; GENETIC INHIBITION; HISTONE ACETYLATION; HISTONE DEACETYLASES;

PROTEINS;

HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; NEUROTOXIN; ENZYME INHIBITOR; HISTONE; HISTONE DEACETYLASE INHIBITOR; NERVE PROTEIN;

ANIMAL CELL; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL FACTOR; ENZYME DEGRADATION; EPIGENETICS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; ACETYLATION; AGED; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CHEMISTRY; DRUG EFFECTS; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; MESENCEPHALON; METABOLISM; PATHOLOGY; PROTEIN PROCESSING; RNA INTERFERENCE; TISSUE BANK;

ACETYLATION; AGED; ANIMALS; AUTOPHAGY; CELL LINE; DOPAMINERGIC NEURONS; ENZYME INHIBITORS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HISTONES; HUMANS; MALE; MESENCEPHALON; MICE; NERVE TISSUE PROTEINS; PARKINSON DISEASE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA INTERFERENCE; TISSUE BANKS;

EID: 84964588067     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M115.675488     Document Type: Article

References (32)

1. Lees, A.J., Hardy, J., and Revesz, T. (2009) Parkinson's disease. Lancet 373, 2055-2066
2. Klein, C., and Westenberger, A. (2012) Genetics of Parkinson's disease. Cold Spring Harb. Perspect. Med. 2, a008888
3. Song, C., Kanthasamy, A., Anantharam, V., Sun, F., and Kanthasamy, A. G. (2010) Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration. Mol. Pharmacol 77, 621-632
4. Manikkam, M., Guerrero-Bosagna, C., Tracey, R., and Haque, M. M., and Skinner, M. K. (2012) Transgenerational actions of environmental compounds on reproductive disease and identification of epigenetic biomarkers of ancestral exposures. PLoS ONE 7, e31901
5. Skinner, M. K., Manikkam, M., and Guerrero-Bosagna, C. (2010) Epigenetic transgenerational actions of environmental factors in disease etiology. Trends Endocrinol Metab. 21, 214-222
6. Abel, T., and Zukin, R. S. (2008) Epigenetic targets of HDAC inhibition in neurodegenerative and psychiatric disorders. Curr. Opin. Pharmacol. 8, 57-64
7. Jaenisch, R., and Bird, A. (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33, 245-254
8. Goldberg, A. D., and Allis, C. D., and Bernstein, E. (2007) Epigenetics: a landscape takes shape. Cell 128, 635-638
9. Ayyanathan, K., and Lechner, M. S., Bell, P., Maul, G. G., and Schultz, D. C., Yamada, Y., Tanaka, K., Torigoe, K., Rauscher, F. J., 3rd. (2003) Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes Dev. 17, 1855-1869
10. Gräff, J., Kim, D., Dobbin, M. M., and Tsai, L. H. (2011) Epigenetic regulation of gene expression in physiological and pathological brain processes. Physiol. Rev. 91, 603-649
11. Francis, Y. I., Fà, M., Ashraf, H., Zhang, H., Staniszewski, A., Latchman, D. S., and Arancio, O. (2009) Dysregulation of histone acetylation in the APP/PS1 mouse model of Alzheimer's disease. J. Alzheimers Dis. 18, 131-139
12. Monti, B., Gatta, V., Piretti, F., Raffaelli, S. S., Virgili, M., and Contestabile, A. (2010) Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of a-synuclein. Neurotox. Res. 17, 130-141
13. Outeiro, T. F., Kontopoulos, E., Altmann, S. M., Kufareva, I., and Strathearn, K. E., Amore, A. M., Volk, C. B., and Maxwell, M. M., Rochet, J. C., McLean, P. J., and Young, A. B., Abagyan, R., Feany, M. B., and Hyman, B. T., and Kazantsev, A. G. (2007) Sirtuin 2 inhibitors rescue a-synuclein-mediated toxicity in models of Parkinson's disease. Science 317, 516-519
14. Kim, S. J., and Park, G. H., Kim, D., Lee, J., Min, H., Wall, E., Lee, C. J., and Simon, M. I., Lee, S. J., and Han, S. K. (2011) Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons. Proc. Natl. Acad. Sci. U.S.A. 108, 3371-3376
15. Jackson-Lewis, V., and Przedborski, S. (2007) Protocol for the MPTP mouse model of Parkinson's disease. Nature Protocols 2, 141-151
16. +-induced neurotoxicity in vivo: the involvement of mitochondria and a-synuclein aggregation. PLoS ONE 9, e91074
17. Zhu, J. H., Horbinski, C., Guo, F., Watkins, S., Uchiyama, Y., and Chu, C. T. (2007) Regulation of autophagy by extracellular signal-regulated protein kinases during 1-methyl-4-phenylpyridinium-induced cell death. Am. J. Pathol. 170, 75-86
18. Sheen, J. H., Zoncu, R., Kim, D., and Sabatini, D. M. (2011) Defective regulation of autophagy upon leucine deprivation reveals a targetable liability of human melanoma cells in vitro and in vivo. Cancer Cell 19, 613-628
19. Dokmanovic, M., Clarke, C, and Marks, P. A. (2007) Histone deacetylase inhibitors: overview and perspectives. Mol. Cancer Res. 5, 981-989
20. Cicchetti, F., Drouin-Ouellet, J., and Gross, R. E. (2009) Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? Trends Pharmacol. Sci. 30, 475-483
21. Di Monte, D. A. (2003) The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins? Lancet Neurol. 2, 531-538
22. Langston, J. W., Ballard, P. A., Jr. (1983) Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine. New Engl. J. Med. 309, 310
23. Gu, X., Sun, J., Li, S., Wu, X., and Li, L. (2013) Oxidative stress induces DNA demethylation and histone acetylation in SH-SY5Y cells: potential epigenetic mechanisms in gene transcription in Abeta production. Neurobiol. Aging 34, 1069-1079
24. Vincow, E. S., Merrihew, G., Thomas, R. E., and Shulman, N. J., Beyer, R. P., MacCoss, M. J., and Pallanck, L. J. (2013) The PINK1-Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo. Proc. Natl. Acad. Sci. U.S.A. 110, 6400-6405
25. Kim, D., and Frank, C. L., Dobbin, M. M., Tsunemoto, R. K., Tu, W., Peng, P.L., and Guan, J. S., Lee, B. H., Moy, L. Y., Giusti, P., Broodie, N, Mazitschek, R., Delalle, I., Haggarty, S. J., and Neve, R. L., Lu, Y., and Tsai, L. H. (2008) Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity. Neuron 60, 803-817
26. Kontopoulos, E., and Parvin, J. D., and Feany, M. B. (2006) α-Synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum. Mol. Genet. 15, 3012-3023
27. Song, C, Kanthasamy, A., Jin, H., Anantharam, V., and Kanthasamy, A. G. (2011) Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration. Neurotoxicology 32, 586-595
28. Haberland, M., Johnson, A., Mokalled, M. H., Montgomery, R. L., and Olson, E. N. (2009) Genetic dissection of histone deacetylase requirement in tumor cells. Proc. Natl. Acad. Sci. U.S.A. 106, 7751-7755
29. Ropero, S., and Esteller, M. (2007) The role of histone deacetylases (HDACs) in human cancer. Mol Oncol 1, 19-25
30. Harrison, I. F., and Dexter, D. T. (2013) Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease? Pharmacol. Ther. 140, 34-52
31. Glozak, M. A., Sengupta, N, Zhang, X., and Seto, E. (2005) Acetylation and deacetylation of non-histone proteins. Gene 363, 15-23
32. Zhang, Y., Li, N, Caron, C, Matthias, G., Hess, D., Khochbin, S., and Matthias, P. (2003) HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J. 22, 1168-1179